公开(公告)号：US20130178536A1

公开(公告)日：2013-07-11

申请号：US13744719

申请日：2013-01-18

Applicant: STC. UNM

Inventor： David L. Vander Jagt ,  Lorraine M. Deck ,  Robert E. Royer ,  John E. Heidrich ,  Laurel O. Sillerud

IPC: A61K31/136 ,  A61K31/05 ,  A61K31/085

CPC classification number: A61K31/136 ,  A61K31/05 ,  A61K31/085 ,  A61K31/381 ,  A61K31/44 ,  A61K31/525 ,  A61K31/66 ,  C07D213/30 ,  C07D333/16

Abstract: The present invention relates to method(s) of treating a subject afflicted with cancer or a precancerous condition, an inflammatory disease or condition, and/or stroke or other ischemic disease or condition, the method comprising administering to the subject or patient in need a composition comprising a therapeutically effective amount of a substituted cis or trans-stilbene. A method of treating or reducing the likelihood of Alzheimer's disease in a patient is an additional embodiment of the present invention.

Abstract translation: 本发明涉及治疗患有癌症或癌前病症，炎性疾病或病症，和/或中风或其他缺血性疾病或病症的受试者的方法，所述方法包括对需要的受试者或患者施用 组合物，其包含治疗有效量的取代的顺式或反式二苯乙烯。 治疗或降低患者中阿尔茨海默氏病的可能性的方法是本发明的另外的实施方案。